Sometimes, more is better

Journal of Infectious Diseases

Volumn 205, Issue 5, 2012, Pages 697-699

  Overton, Edgar Turner ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADVERSE OUTCOME; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DETECTION; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; FOLLOW UP; HEMAGGLUTINATION INHIBITION; HIGH RISK PATIENT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; NOTE; PRIORITY JOURNAL; SEROCONVERSION; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANTIGENS, VIRAL; FEMALE; FEVER; HEMAGGLUTININS; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS;

EID: 84856831453     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir838     Document Type: Note

References (24)

1. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1128-32.
2. Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis 2011; 52:219-27.
3. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441-6. (Pubitemid 32116562)
4. Garbino J, Inoubli S, Mossdorf E, et al. Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS 2008; 22:701-5. (Pubitemid 351450638)
5. Klein MB, Yang H, DelBalso L, Carbonneau J, Frost E, Boivin G. Viral pathogens including human metapneumovirus are the primary cause of febrile respiratory illness in HIVinfected adults receiving antiretroviral therapy. J Infect Dis 2010; 201:297-301.
6. Klein MB, Lu Y, DelBalso L, Coté S, Boivin G. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007; 45:234-40. (Pubitemid 47041016)
7. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
8. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172:3437-46. (Pubitemid 38337923)
9. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics 2006; 118:e579-85. (Pubitemid 46091609)
10. Saad CG, Borba EF, Aikawa NE, et al. Immunogenicity and safety of the 2009 nonadjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis 2011; 70:1068-73.
11. Cooper C, Hutton B, Fergusson D, et al. A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. Can J Infect Dis Med Microbiol 2008; 19:419-23.
12. Anema A,Mills E, Montaner J, Brownstein JS, Cooper C. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 2008; 9:57-61.
13. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
14. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199-202. (Pubitemid 35471246)
15. Steinman RM. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med 2007; 13:1155-9. (Pubitemid 47530635)
16. El Sahly HM, Davis C, Kotloff K, et al. Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. J Infec Dis 2011; 205:703-12.
17. Tebas P, Frank I, Lewis M, et al. Impact of the type of seasonal influenza vaccine on immune responses to the 2009 pandemic influenza A (H1N1) vaccine. AIDS 2010; 24: 2187-92.
18. Tiu CT, Lin YS, Pagala M, et al. Antibody response to inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with and without HIV. J Acquir Immune Defic Syndr 2011; 58:e99-102.
19. Crum-Cianflone NF, Iverson E, Defang G. The Infectious Disease Clinical Research Program Working Group. Impact of the type of seasonal influenza vaccine on immune responses to the 2009 pandemic influenza A (H1N1) vaccine. Vaccine 2011; 29:9294-5.
20. Cooper C, Thorne A, Klein M, et al. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PLoS One 2011; 6: e17758.
21. McKittrick N, Frank I, Jacobson J, et al. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected individuals: The results of a double-blinded, randomized trial comparing Fluzone High-Dose with Fluzone. In: Program and abstracts of the 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA: 2012; P-148.
22. Durham MD, Buchacz K, Armon C, et al. Rates and correlates of influenza vaccination among HIV-infected adults in the HIV Outpatient Study (HOPS), USA, 1999-2008. Prev Med 2011; 53:89-94.
23. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, doubleblind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009; 200:172-80.
24. Sullivan SJ, Jacobson R, Poland GA. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev Vaccines 2010; 9:1127-33.